| Nombre del producto |
Nelfinavir |
| Nombre en inglés |
Nelfinavir; 3-isoquinolinecarboxamide,n-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hy; 8a-beta))-a-bet; nefinavir; (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide methanesulfonate (1:1); (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide |
| Fórmula molecular |
C32H45N3O4S |
| Peso Molecular |
567.7824 |
| InChI |
InChI=1/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1 |
| Número de registro CAS |
159989-64-7 |
| Estructura Molecular |
|
| Densidad |
1.22g/cm3 |
| Punto de ebullición |
786.8°C at 760 mmHg |
| Índice de refracción |
1.618 |
| Punto de inflamación |
429.7°C |
| Presión de vapor |
4.38E-26mmHg at 25°C |
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
